Remote Patient Monitoring Market Snapshot

Key Players

  • Philips (Netherlands)
  • Medtronic (Ireland)
  • GE HealthCare (United States)
  • Abbott Laboratories (United States)
  • ResMed (United States)
  • iRhythm Technologies (United States)
  • Masimo (United States)
  • BioBeat (Israel)
  • Withings (France)
  • Dozee (India)

Market Size

Base Year 2024
$ 28.56 Bn
CAGR
11.2%
Forecast 2034
$ 82.63 Bn

Market Segments

By Product
  • Specialized Monitors
  • Vital Sign Monitors
By Application
  • Diabetes
  • Cancer
  • Virus
  • Weight Management
  • Cardiovascular Diseases
  • Bronchitis
  • Sleep Disorder
  • Dehydration
  • Hypertension
  • Others
By End Use Industry
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

Market Dynamics

Drivers
  • Growing chronic disease prevalence
  • Rising adoption of telehealth
Restraints
  • High device implementation costs
  • Data privacy and security concerns
Opportunities
  • Increased chronic disease prevalence
  • Expansion of telehealth infrastructure
Trends
  • Increased chronic disease prevalence
  • Growing elderly patient population

Market Size

The Remote Patient Monitoring Market is valued at 31.77 billion USD in 2025 and is projected to reach 82.63 billion USD by 2034, with a CAGR of 11.2%. The market starts at 28.56 billion USD in 2024, indicating strong growth over the coming years. This expansion is attributed to increasing healthcare demands and advancements in technology related to remote monitoring solutions. Additionally, the growing focus on patient-centered care fosters the adoption of remote patient monitoring systems. In 2024, the regional share mix is as follows: North America at 42.7%, Asia Pacific at 33.9%, Europe at 14.9%, LATAM at 5.5%, and MEA at 3.0%.

Key Takeaways

  • By Product - Vital Sign Monitors held the leading position with significant market share in the Remote Patient Monitoring Market.
  • By Application - Diabetes emerged as the fastest-growing segment with a notable increase in demand and utilization.
  • By End Use Industry - Homecare Settings demonstrated the strongest expansion trajectory in the Remote Patient Monitoring Market.
remote-patient-monitoring-market market size

Key Driving Factors

Adaption to COVID-19 Pandemic Constraints

During the COVID-19 pandemic, the necessity for social distancing and limiting exposure to healthcare facilities has amplified demand for remote patient monitoring (RPM). Health organizations worldwide are shifting towards a more digital approach to reduce physical interactions and virus spread. RPM allows healthcare providers to monitor patients' vital signs, medication adherence, and complete health data without requiring a physical presence. It can also provide critical healthcare access to someone who may otherwise avoid or be unable to visit a hospital or clinic due to the fear of infection. This shift in healthcare service delivery due to the pandemic is a significant driver for the RPM market.

The Escalation of Chronic Conditions

The increasing prevalence of chronic illnesses, such as diabetes, cardiovascular diseases, and respiratory disorders, is driving the remote patient monitoring market. Managing chronic diseases necessitates frequent tracking and assessment of patient health, making RPM an effective solution. Patients can use wearable devices to monitor vitals such as blood sugar, heart rate, or oxygen levels, and these readings can be remotely accessed by physicians for evaluation. This method substantially reduces the number of routine visits chronic patients make to healthcare facilities. With RPM, physicians can proactively respond to concerning fluctuations in vitals, allowing for timely intervention and superior disease management. Thus, the upsurge of chronic diseases globally is accelerating the RPM market growth.

Market Evolution by Timeline

2019-2023
During the period from 2019 to 2023, the Remote Patient Monitoring (RPM) market saw significant growth, especially in the United States and parts of Europe. Key buyers included hospitals, outpatient clinics, and insurance companies that sought to reduce readmission rates and improve chronic disease management. The COVID-19 pandemic accelerated adoption, with solutions like telehealth integration becoming standard practice in areas like New York City. Major technologies piloted included wearable devices and mobile health applications, which allowed real-time health tracking. However, integration was often inconsistent due to varying electronic health record (EHR) systems and data interoperability issues. The Centers for Medicare and Medicaid Services (CMS) introduced new billing codes to reimburse RPM services, providing a financial incentive for providers. Typical contracts included subscription models for software licensing, but many buyers were still cautious, citing concerns over patient data security. The market also faced challenges such as regulatory changes and the need for healthcare providers to train staff on new technologies.
2024
In 2024, the Remote Patient Monitoring market focused on expanding its buyer base to include more rural healthcare systems and nursing facilities across the United States. The market saw increased integration of RPM tools with existing electronic health records, particularly in regions like the Midwest, where initiatives funded by state healthcare programs emerged. For example, state-sponsored programs provided grants to small hospitals for RPM implementation. New industry standards concerning patient data security were proposed to address privacy concerns. Commercial models evolved with more organizations adopting pay-per-use pricing to accommodate budget constraints. Partnerships between tech companies like Philips and healthcare providers became common to facilitate smooth onboarding. Obstacles such as limited broadband access in rural areas and resistance from older patients to adopt new technologies required continuous education efforts. As a response, providers began offering in-home demonstrations and remote support to alleviate concerns and improve technology acceptance.
2025-2029
From 2025 to 2029, the Remote Patient Monitoring market experienced a marked shift towards comprehensive care models, integrating RPM with chronic disease management and preventative care in countries such as Canada and Australia. Buyer segments diversified, with increasing interest from pharmaceutical companies looking to monitor drug adherence and outcomes. The integration of artificial intelligence into RPM devices began to show promising results in predictive analytics, particularly in managing diabetes and cardiovascular diseases. Regulations began to solidify with the introduction of the Digital Health Innovation Action Plan in several regions, dictating standards for device interoperability and patient privacy. Fixed subscription models became less common as pay-for-performance contracts gained traction, aligning provider reimbursement with patient outcomes. A growing focus on outcomes over volume shaped the market's operational dynamics. However, challenges with patient engagement persisted, especially among elderly populations. Providers invested in user-friendly interfaces and ongoing patient education to address these barriers, leading to better adoption rates.
2030-2034
In the years 2030 to 2034, the Remote Patient Monitoring market is likely to move towards mainstream healthcare practices with high integration levels within hospital care pathways across North America and Europe. The widespread use of 5G technology will enhance real-time data transmission from devices and reduce latency issues significantly. As a result, a broader array of devices including smart clothing and implantable sensors are expected to become commonplace. Buyer segments will expand further to include wellness and preventive care sectors, with businesses incentivizing RPM for employee health management. Government policies may mandate RPM for eligible chronic conditions under public health programs, confirming its critical role in healthcare ecosystems. Commercial models will see continued evolution with bundled payments for integrated services becoming standard. Partnerships with non-healthcare entities, like tech firms, are expected to flourish to facilitate device development and improve user experience. Expected barriers will include device standardization and the need for extensive infrastructure upgrades, particularly in developing regions, which could slow regional adoption despite global trends.

Future Market Outlook

Technology Trends

The remote patient monitoring market has witnessed increased adoption since 2020, particularly due to the COVID-19 pandemic, which expedited the integration of telehealth solutions into healthcare systems across many countries. In 2021, the Centers for Medicare and Medicaid Services in the United States expanded reimbursement policies for remote monitoring services, thus encouraging healthcare providers to adopt these technologies. Companies like Philips launched monitoring systems such as the Philips HealthSuite, which enables the collection and analysis of patient data in real time. The development of wearable devices by firms like Fitbit and Apple has shown substantial capabilities for continuous health monitoring, contributing to a rise in consumer awareness and trust in these technologies. Regulatory bodies, including the European Medicines Agency, have proposed frameworks for the approval of software as a Medical Device (SaMD), setting standards for quality and safety in the market. Furthermore, advancements in artificial intelligence and machine learning have enhanced data analytics capabilities, enabling providers to derive actionable insights from patient data. In April 2022, the International Telecommunication Union published guidelines for implementing IoT in health applications, emphasizing the importance of interoperability among devices. As a result, the market is trending towards increasingly interconnected and sophisticated platforms that allow seamless patient data exchange and improved care management practices.

Future Opportunities

In the evolving landscape of remote patient monitoring, significant opportunities exist for innovation and growth driven by current technological advancements and regulatory changes. The ongoing push for integrated care models, as outlined by policy initiatives from organizations like the World Health Organization, is encouraging healthcare providers to enhance coordination using remote monitoring technologies. Collaborations between tech companies and healthcare providers, such as the partnership between Amazon and the Cleveland Clinic in 2021, illustrate the potential for expanding service offerings in this space. Moreover, the expanding role of chronic disease management programs presents an opportunity for monitoring solutions to become integral in patient care strategies, aiming to improve patient outcomes and reduce healthcare costs. The introduction of 5G networks globally is expected to significantly enhance the efficiency of data transmission, thus enabling real-time monitoring and responsiveness. The 2022 update by the FDA introduced new guidelines for digital health devices, further motivating companies to invest in compliance and innovation. Enhanced data security measures, following cybersecurity incidents reported by healthcare institutions, can also fuel demand for safer remote monitoring solutions. The emphasis on patient engagement, driven by consumer interest in personalized healthcare, is likely to influence product development priorities among tech companies operating in the remote monitoring sector. As stakeholders increasingly recognize these trends, the potential for scalable and transformative patient care solutions will likely expand.

Segmentation Analysis

The remote patient monitoring market is segmented into Product (Specialized Monitors, Vital Sign Monitors), Application (Diabetes, Cancer, Virus, Weight Management, Cardiovascular Diseases, Bronchitis, Sleep Disorder, Dehydration, Hypertension, Others), and End Use Industry (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare Settings).

By Product

By Product, the market is segmented into specialized monitors and vital sign monitors. The vital sign monitors subsegment accounted for the largest revenue share in 2024. The specialized monitors subsegment is expected to grow at the fastest CAGR during the forecast period.

Largest Revenue Share

Vital Sign Monitors

Market Share Leader

Vital Sign Monitors dominate the market primarily due to their critical role in patient care across multiple healthcare settings. These devices are essential for tracking patients' key health metrics such as heart rate, blood pressure, and oxygen saturation, making them indispensable in emergency rooms and intensive care units. The driving force behind their revenue growth is the increasing prevalence of chronic diseases and the aging population, which heightens the demand for constant health monitoring. Geographically, North America leads in consumption owing to advanced healthcare infrastructure and a high level of healthcare expenditure. Stringent regulations regarding patient safety and monitoring standards further boost this segment, as hospitals look to comply with industry mandates. Purchasing criteria include accuracy, reliability, and integration capabilities with electronic health record systems, driving healthcare facilities to invest in high-quality monitors. Furthermore, switching costs are significant, as hospitals often have to train staff and invest in compatible equipment, which can deter them from changing brands frequently. This amalgamation of clinical necessity, regulatory compliance, and the demand for advanced technology solidifies Vital Sign Monitors as the highest revenue-generating subsegment in the market today.

Fastest CAGR

Specialized Monitors

Forecast Period Growth Leader

Specialized Monitors are projected to exhibit the fastest growth due to advancements in technology tailored for specific conditions, such as neurological or cardiac monitoring, responding to the increasing recognition of personalized healthcare. The rising prevalence of cardiovascular diseases and neurological disorders, coupled with rapid technological advancements in data analytics and connectivity, serves as a primary driver for this segment. Adoption barriers include the higher upfront costs involved in acquiring advanced specialized devices, which may limit access in emerging markets. However, supporting policies promoting telehealth and remote monitoring are catalysts for growth, encouraging hospitals to invest in specialized technologies to provide better patient outcomes. Strategic partnerships between technology firms and healthcare providers are also forming to enhance capabilities in data collection and real-time monitoring. Near-term risks include evolving regulatory landscapes and rapid technological changes, which could make current products obsolete. Despite these challenges, the unique ability of Specialized Monitors to deliver targeted healthcare solutions and improve patient management makes this subsegment a rapidly expanding market opportunity.

By Application

By Application, the market is segmented into diabetes, cancer, virus, weight management, cardiovascular diseases, bronchitis, sleep disorder, dehydration, hypertension, and others. The diabetes subsegment held the largest revenue share in 2024. The weight management subsegment is expected to grow at the fastest CAGR during the forecast period.

Largest Revenue Share

Diabetes

Market Share Leader

The Diabetes subsegment is projected to generate the highest revenue in the healthcare market by 2024, driven by a rapidly increasing prevalence of diabetes globally. A significant proportion of adults are experiencing type 2 diabetes due to lifestyle factors, which translates to heightened demand for effective management solutions. Geographically, North America and Europe are leading markets due to their advanced healthcare infrastructure and a higher awareness of diabetes management products. Regulatory support, including favorable policies that encourage the development and reimbursement of diabetes care technologies, enhances the attractiveness of this subsegment. Additionally, strong purchasing criteria focus on the efficacy and safety of therapeutic solutions, increasing the switching costs for customers who invest in treatment regimens and devices. The channel landscape is similarly robust, with a blend of retail, online, and healthcare provider distributions facilitating easy access to diabetes management products. As a result, the Diabetes subsegment remains imperative for investors and stakeholders, representing the forefront of opportunities within the healthcare landscape as populations continue to adapt to evolving health challenges.

Fastest CAGR

Weight Management

Forecast Period Growth Leader

The Weight Management subsegment is anticipated to achieve the fastest growth in the coming years, driven by increasing health consciousness among consumers and the growing prevalence of obesity-related diseases. Adoption barriers include varying perceptions of weight management solutions; however, technological innovations, such as data-driven applications and personalized dietary plans, are catalyzing expansion in this sector. Partnerships among technology providers, healthcare professionals, and wellness companies are fostering a more integrated approach to weight management, simplifying user engagement and enhancing outcomes. Regulatory guidelines promoting healthier lifestyle choices will further propel growth, allowing businesses to capitalize on favorable market conditions. Immediate risks include potential market saturation and a backlash against diet-specific trends; however, the trend toward sustainable, holistic health approaches mitigates these threats. As consumers demand more personalized and accessible weight management solutions, this subsegment stands poised for remarkable growth, making it vital for stakeholders to adapt to emerging trends and consumer preferences swiftly.

By End Use Industry

By End Use Industry, the market is segmented into hospitals & clinics, ambulatory surgical centers, and homecare settings. The hospitals & clinics subsegment accounted for the largest revenue share in 2024. The homecare settings subsegment is expected to grow at the fastest CAGR during the forecast period.

Largest Revenue Share

Hospitals & Clinics

Market Share Leader

In 2024, the Hospitals & Clinics subsegment is expected to generate the most revenue within the healthcare market. This can be attributed to a combination of factors, including the high volume of patient care provided and the complexity of services offered. Hospitals are often the first point of contact for patients requiring urgent, specialty, or comprehensive care, driving steady demand. In particular, the increasing prevalence of chronic diseases necessitates constant patient monitoring and treatment, which hospitals are well-equipped to provide. Geographically, urban centers tend to have a higher concentration of hospitals, which capture a significant share of the population seeking medical attention. Regulatory support, such as increased funding and quality incentives, further bolster the revenue potential for these facilities. Additionally, the purchasing criteria focus on high-quality medical equipment and staffing, essential for maintaining operational efficiency. Switching costs for patients are relatively high, as individuals often prefer established care relationships with local hospitals. Consequently, this entrenched position in the healthcare ecosystem positions hospitals and clinics favorably, allowing them to capitalize on ongoing healthcare trends and evolving patient needs.

Fastest CAGR

Homecare Settings

Forecast Period Growth Leader

Homecare Settings are on track to achieve the fastest growth trajectory in the coming years, driven by the rising demand for personalized and convenient healthcare solutions. The aging population is a crucial growth driver, as many elderly individuals prefer to receive care in the comfort of their homes rather than in institutional settings. Innovations in telehealth and remote monitoring technologies are acting as significant catalysts for this trend, facilitating quicker adoption among both healthcare providers and patients. Regulatory shifts favoring home-based care, such as reimbursement policies that encourage outpatient services, further contribute to this segment's expansion. However, challenges persist, including ensuring quality control and managing the integration of technology into traditional care models. Partnerships between home health agencies and hospitals are vital to mitigate these risks by streamlining patient transitions from hospital to home. Near-term risks include potential variability in policy frameworks that could impact funding and access to services. Maintaining a focus on quality care delivery and patient satisfaction will be essential for stakeholders looking to capitalize on this rapidly evolving market segment.

Competitive Analysis

Key Market Players

The Remote Patient Monitoring Market is competitive, with a mix of large established companies and smaller regional players. Most companies focus on improving their products/services, keeping prices attractive, and strengthening relationships with key customers. They also use partnerships, acquisitions, and new launches to expand their presence in existing and new markets. Overall, players compete on quality, reliability, and value, and competition is expected to remain strong over the forecast period.

Manufacturers / OEMs

Philips
Netherlands
GE Healthcare
US
Medtronic
Ireland

Key Suppliers & Raw Materials

Texas Instruments
US
STMicroelectronics
Switzerland
Analog Devices
US

Distributors, Integrators & Channel Partners

McKesson Corporation
US
Cerner Corporation
US
Roche Diagnostics
Switzerland

Porter’s Five Forces Analysis

This analysis evaluates the competitive dynamics of the Remote Patient Monitoring market. It highlights the forces affecting profitability and market strategy.

Supplier Bargaining Power

Medium

Suppliers are moderate in power due to specialized technology and limited manufacturers in certain categories.

Buyer Bargaining Power

High

Buyers wield significant power due to numerous alternative providers and low switching costs.

Threat of Substitutes

High

Alternative health monitoring solutions, like wearable devices, pose a strong threat to traditional services.

Threat of New Entrants

Medium

Entry barriers exist due to regulatory approvals and technological requirements, but the market is attractive.

Competitive Rivalry

High

Intense competition exists among established firms, driving innovation and pricing pressures in the market.

Regional Analysis

Geographic market dynamics and growth opportunities across key regions

Global Market Outlook

remote-patient-monitoring-market market regional share

North America

In 2024, the Remote Patient Monitoring (RPM) market in North America is characterized by the increased adoption of digital health solutions aimed at improving patient outcomes and reducing healthcare costs. Key drivers of this market include a rising demand for chronic disease management tools, which is spurred by an aging population and a growing prevalence of conditions such as diabetes and hypertension. Regulatory frameworks, notably the 21st Century Cures Act in the U.S., facilitate the integration of remote monitoring into clinical practice, streamlining reimbursement processes. Investment in RPM technologies is supported by healthcare providers seeking to enhance patient engagement and operational efficiency, while advancements in wearables and IoT enable seamless data collection.

Trends shaping the market include a shift toward value-based care, prompting healthcare providers to seek RPM solutions that deliver measurable patient outcomes. Increased consumer awareness of health monitoring apps is influencing buyer behavior, with patients expecting real-time health data access. Established partnerships among technology firms, healthcare providers, and payers are creating comprehensive care models. Legislative enforcements such as the Canadian Health Infoway initiative drive standards for interoperability, ensuring that RPM solutions fit within broader healthcare IT infrastructures, thereby enhancing their adoption across sectors.

Asia Pacific

In 2024, the Remote Patient Monitoring (RPM) market in Asia Pacific is characterized by rapid adoption and investment driven by rising healthcare demands. In China, an aging population and increased chronic disease prevalence amplify the need for effective monitoring solutions, supported by government policies promoting digital health initiatives. India experiences similar pressures, where urbanization and scarce healthcare resources drive demand for affordable RPM technologies. Japan’s advanced healthcare system facilitates a shift towards RPM, with technology integration in hospitals becoming more common. South Korea benefits from strong government backing, as seen in the Health Insurance Review and Assessment Service’s incentive programs for telehealth solutions, which encourage RPM uptake.

Trends indicate a shift in buyer behavior as healthcare providers invest in RPM to enhance patient outcomes and operational efficiency. Increased collaboration among technology firms and healthcare providers leads to innovative solutions, exemplified by partnerships between telecom companies and medical institutions to expand RPM services. Consumer acceptance of telehealth drives RPM channel dynamics, making it integral to primary care models. Regulatory environments in key ASEAN markets are evolving, aligning with international standards to facilitate RPM implementation, thereby reinforcing healthcare systems' resilience and enhancing overall service delivery in the sector.

Europe

In 2024, the Remote Patient Monitoring (RPM) market in Europe is characterized by rapid technological advancements and a growing emphasis on patient-centric care. The increasing prevalence of chronic diseases has heightened demand for RPM solutions, particularly in major markets like Germany and the United Kingdom, where healthcare systems face pressure to reduce costs while enhancing care quality. Government regulations, such as Germany's Digital Healthcare Act, incentivize the adoption of digital health tools, accelerating market growth.

Technological adoption is driven by the integration of Internet of Things (IoT) devices and cloud-based platforms, which enhance real-time patient data collection and management. Partnerships between healthcare providers and technology firms are becoming common as entities seek comprehensive RPM solutions, exemplified by collaborations in France and the Nordics.

Consumer behavior reflects a shift towards proactive health management, as patients increasingly prefer RPM solutions for chronic condition management. The rise of telemedicine has also influenced channel dynamics, with healthcare providers expanding into direct-to-consumer models. Standards for data protection, influenced by GDPR, are shaping how health data is processed and utilized, necessitating robust compliance frameworks across the Benelux and Central & Eastern European markets. Collectively, these drivers and trends illustrate a dynamic RPM landscape in Europe.

Latin America

In 2024, the Remote Patient Monitoring (RPM) market in Latin America is defined by the integration of technology into healthcare systems across key nations. Drivers such as increasing chronic disease prevalence and a growing aging population are propelling demand for RPM solutions. In Brazil, favorable regulatory frameworks like the Healthtech Regulatory Sandbox are facilitating innovation and adoption. Mexico's healthcare reforms are encouraging investment in digital health technologies, while Colombia's integration of telemedicine into public health policy is enhancing RPM usage. Furthermore, the growing presence of health-tech startups is expanding supply dynamics and fostering competitive pricing.

Trends in the RPM market include a significant shift towards patient-centered care, with consumers increasingly favoring home-based monitoring solutions. The demand for wearable health technology is rising, driven by advancements in sensor technology and smartphone integration. Partnerships between technology firms and healthcare providers, particularly in Argentina and Chile, are strengthening market access and service delivery. Government initiatives, such as Peru’s telehealth strategy, are reinforcing the role of RPM in public health. Overall, the market is shaped by evolving buyer behavior that prioritizes convenience and efficiency, alongside an increasing emphasis on regulatory compliance and standardization in health services across the region.

Middle East & Africa

In 2024, the Remote Patient Monitoring (RPM) market in the Middle East and Africa is characterized by increasing demand for healthcare efficiency and patient-centered care. Key drivers include a rising prevalence of chronic diseases, facilitating a need for continuous health monitoring. Governments, especially in Saudi Arabia and the UAE, are implementing digital health initiatives, like the Saudi Vision 2030, which promotes the adoption of technologies to enhance healthcare services. Investment from both public and private sectors is boosting RPM capabilities, with significant funding directed towards startups and technology integrators within the region. Additionally, enhanced connectivity through telecommunications advancements is supporting widespread RPM deployment.

Trends indicate a shift towards integrated healthcare solutions, with hospitals in South Africa and Egypt increasingly offering RPM services to streamline patient management. The growing familiarity with health apps is changing buyer behavior, as patients seek more control over their health data. Partnerships between healthcare providers and technology firms are becoming common, focusing on interoperability and data security, crucial in compliance with regulations such as the Personal Data Protection Law in Israel. Overall, the RPM market in this region is evolving under a framework of government support, market demand, and technological advancement, aiming to improve healthcare accessibility and outcomes.

Recent Industry Developments

Latest market innovations, product launches, and strategic initiatives

July 2024

Bon Secours Mercy Health entered a 10-year partnership with Philips to implement and scale a new remote patient monitoring platform across 49 hospitals and 1,200 care sites, aimed at improving patient outcomes and reducing hospital readmissions.

April 2024

OMRON Healthcare acquired Luscii, a remote patient monitoring company, to accelerate the adoption of RPM solutions with their integrated care platform focused on cardiovascular and cerebrovascular health.

November 2023

CoachCare acquired MD Revolution, a leading remote care management platform, creating a combined entity focused on chronic disease management and remote care delivery at scale.

Frequently Asked Questions

Recent Blogs

Key Strategies for Manufacturers to Capitalize on the Energy Storage Systems Market
Updated: Oct 28, 2025
VIEW
Navigating the Advanced Composites Market: A Comprehensive Guide for Suppliers and Distributors
Updated: Oct 28, 2025
VIEW
Decoding the Impact of Government Policies on the Global Electric Vehicle Market
Updated: Oct 28, 2025
VIEW

Recent News

Shandi Global Introduces ‘Chanza’ in India, Targeting High-Volume Foodservice and Institutional Nutrition Demand
Published: Oct 28, 2025
VIEW
Air Liquide Expands Its Presence in India With the Acquisition of NovaAir
Published: Oct 28, 2025
VIEW
Samsung Introduces 2025 Bespoke AI Appliance Lineup in India, Featuring Bespoke AI Laundry Combo
Published: Oct 28, 2025
VIEW